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Abstract
Age-related effects of the vascular wall have been associated with several
hemodynamic dysfunctions, including medial vascular calcification. Vascular
aging has been traditionally addressed using proliferative senescence of vascu-
lar smooth muscle cells (VSMC) in vitro, which induces osteoblastic transition
and favors calcification in vitro. In this work, we have analyzed the relation-
ship between organismal aging and proliferative senescence by comparing the
proliferative aging of VSMC obtained from young, mature, and old rats (2-,
12-, and 24-month cell lines [CL], respectively). VSMC proliferated to more
than 100 cumulative population doublings (CPD) without evidence of prolif-
erative senescence, most likely as a consequence of telomerase induction. The
apoptosis rate increased with CPD in all three CL, but the oxidation status of
the cells was not modified. The magnitude of all gene expression changes
caused by CPD was higher than the magnitude of the changes caused by
donor age: the expressions of VSMC markers a-actin and SM22a decreased,
while the expressions of transcription factors Msx2 and Runx2 and of bone
morphogenetic protein-2 increased. Treatment of the cells with 2 mmol/L Pi
revealed that the intensity of the effect of CPD on calcium deposition was
greater than the effect of donor age. In conclusion, the proliferative lifespan of
VSMC magnifies the effect of donor age on the osteoblastic transition of
VSMC, therefore suggesting that in vivo vascular aging changes can be less
dramatic than what is shown by in vitro aging.
Introduction
Aging is a multifactorial, degenerative process that affects
all animal species, and it is disclosed when individuals are
protected from environmental hazards such as predation,
accidents, starvation, or disease. The immediate conse-
quence of this protection is increased survival, which
according to the disposable soma theory (Kirkwood 1977)
causes the progressive depletion (i.e., aging) of species
specific, functional, metabolic, and repair reserves when
the reproductive age is exceeded. At a cellular scale,
aging affects both postmitotic and proliferative cells, with
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different consequences. In proliferative cells, senescence
refers to the irreversible arrest of cell division in vitro
when the Hayflick limit is reached after a progressive
slowing down of cell division (Hayflick 1965). While
senescence is optimistically interpreted as an oncosup-
pressive mechanism, antagonistic pleiotropy also reveals
the negative consequences of senescence in organismal
aging: the progressive loss of proliferative capacity is also
accompanied, at the postreproductive age, by the genomic
instability of cells, telomere shortening, epigenetic
changes, and phenotype alterations such as secretory
transformation (Campisi 2013; Lopez-Otın et al. 2013).
Since the discovery of senescent cells in vivo (Dimri
et al. 1995), the accumulation of these cells in tissues has
been associated with many age-related degenerative pro-
cesses (Neves et al. 2015). With respect to vascular biology,
the implication of endothelial and smooth muscle cell
senescence in atherosclerosis and vascular calcification
(VC) has been intensely debated over the last decade (Min-
amino et al. 2002; Burton et al. 2009). Our present work
focuses on the effect of senescence on VC. This ectopic
calcium deposition can affect either the intima (prior to
atheroma) or the media layer of arteries. Medial VC is fre-
quently found in chronic kidney disease (CKD) that occurs
with hyperphosphatemia and uremic “toxins,” but the
prevalence is highest in diabetes, in addition to aging (Lan-
zer et al. 2014). Contrary to the physiological calcification
of bones, the mineralization of arteries causes harmful
effects derived from hardening of the wall, such as hyper-
tension, stiffening, accelerated pulse, deficient peripheral
perfusion, left ventricular overload and dysfunction, etc.
(Lanzer et al. 2014). Deposits of calcium phosphates are
mainly found on elastin fibers, and vascular smooth mus-
cle cells (VSMC) are known to partially transdifferentiate
in bone-forming cells that express osteogenes, such as
Runx2, Msx2, Bmp2, tissue-nonspecific alkaline phos-
phatase (TNAP), etc. (Chen et al. 2006). However, the
pathogenesis of VC is not a common route in all instances.
In the case of CKD, for example, uremic toxins seem to be
a key causative factor in the transdifferentiation of VSMC,
because among other effects, they increase TNAP expres-
sion (Chen et al. 2006). Calcium phosphates are most
likely nucleated on elastic fibers and on VSMC and are
endocytosed, causing cell death (Ewence et al. 2008),
which creates additional nucleation sites and calcium
deposition. Other suggested mechanisms that are involved
in VC include autophagia (Dai et al. 2013), exosome secre-
tion (Kapustin et al. 2015), oxidative stress (Byon et al.
2008), etc. During aging, however, VC mainly occurs in
the absence of uremic toxins or hyperphosphatemia, but it
contributes to the high morbidity and fragility of the
elderly (Dao et al. 2005). VSMC senescence and telomere
shortening have been associated with an increased severity
of atherosclerosis (Matthews et al. 2006). When VSMC
senescence is forced in vitro, the consequent phenotype
predisposes the cells to calcification, with the expression of
several genes that are necessary for osteoblast function,
inflammation, and tissue remodeling, as determined by
microarray screening and quantitative PCR (Nakano-Kuri-
moto et al. 2009; Burton et al. 2010). In addition, nuclear
lamina dysfunction has also been described in senescent
VSMC (Ragnauth et al. 2010). These cells accumulate the
precursor prelamin A, thereby causing mitosis disruption
and DNA damage, which also increases VC through the
secretion of pro-osteogenic factors (Liu et al. 2013).
While most studies on VSMC have been performed
in vitro, senescence markers such as b-galactosidase and
p16 expression have also been observed in vivo in aged rats
(Yang et al. 2007). This information therefore suggests that
the senescence-associated transdifferentiation of VSMC
in vivo could be a major pathogenetic mechanism of VC in
the elderly. Given that the proliferative potential (and
therefore the in vitro senescence) of VSMC is also depen-
dent upon the age of the human donor (Ruiz-Torres et al.
1999), in this work, we aimed to compare the chronologi-
cal (in vivo) and proliferative (in vitro) aging of the cells
and the likely effects on VC predisposition. Considering
that the experimental culture conditions can affect the
aging of cells very differently than what occurs during slow
aging in vivo, our objective was to learn if the phenotypic
changes that are observed during senescence in vitro and
that predispose to ectopic VC are also observed during the
aging of cells in vivo. To do this, we obtained primary
cultures from 2-, 12-, and 24-month-old rats, and we stud-
ied the conservation of the smooth muscle contractile phe-
notype at different cumulative population doublings
(CPD). Simultaneously, we analyzed the expression of a
putative calcification phenotype along the culture life of
the three cell lines (CL), and the findings were correlated
with a molecular characterization of senescence in vitro
and of proliferative lifespan. The final conclusion is that
the phenotypic changes observed during proliferative aging
in vitro are similar to the changes observed in vivo, but
they are of a greater magnitude and are exaggerated by the
experimental conditions in vitro.
Methods
Primary cultures and animals
Vascular smooth muscle cells were obtained by collage-
nase I digestion from the aortas of male Wistar rats
(Janvier SAS, Saint-Berthevin, France) of 2, 12, and
24 months of age, with eight rats per age group, as pub-
lished (Chamley et al. 1977). All studies on animals were
conducted in accordance with the European legislation
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and were previously approved by the Ethical Committee
of the University of Zaragoza. Rats were kept with free
access to food and water, and after deep anesthesia with
pentobarbital, the aortas were obtained and immediately
processed. VSMC were grown in minimum essential med-
ium (MEM) with 10% fetal calf serum, glutamine, and
antibiotics. For the various assays, when the cells reached
90% confluence, they were made quiescent with 0.2%
FCS-containing medium, unless otherwise specified. All
culture reagents were from Gibco (Paisley, UK).
Cell culture growth assay
The analysis of the growth and multiplication of the three
VSMC cultures began after 17 divisions once the primary
cultures had been initiated. For every passage, the cells
were trypsinized, counted, and inoculated in a new flask
at 1 9 104 cells/cm2. The population doubling increase
was calculated as explained (Cristofalo et al. 2000), using
the formula NH/NI = 2
X, where X is the CPD (calculated
as X = {log10[NH]  log10[NI]}/log10[2]), NI is the cell
inoculum number, and NH is the VSMC harvest number.
Gene expression analysis
Gene-specific RNA abundance was analyzed by real-time
PCR in a LightCycler 1.5 using a LightCycler FastStart Mas-
ter SYBR Green I kit (all from Roche, Mannheim,
Germany). We used the DDCT method of relative quantifi-
cation included in the Lightcycle software, with a calibrator
cDNA retrotranscribed from a combination of RNAs from
aortic smooth muscle cells of 2-, 12-, and 24-month-old
rats. Two endogenous reference genes were used: glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) for highly
expressed genes such as smooth muscle markers, and acidic
ribosomal protein (ARP) for moderately expressed genes,
such as newly expressed bone-related RNAs. The primers
used, sense (S) and antisense (AS), were the following:
Runx2: S, CTGCCGAGCTACGAAATGCC; AS, GGCCA
CTTGGGGAGGATTTG.
Msx2: S, ACCGAAGGGCTAAGGCAAAA; AS, CGCTG
TATATGGATGCCGCT.
BMP2: S, GTTCTGTCCCTACTGATGAG; AS, ATTCG
GTGCTGGAAACTAC.
MGP: S, AACACCTTTATATCCCCTCAGC; AS, GCG
TTGTACCCGTAGATCAG.
Sm22a: S, CAGACTGTTGACCTCTTTGAAG; AS, TC
TTATGCTCCTGGGCTTTC.
ARP: S, CACCTTCCCACTGGCTGAA; AS, TCCTCC
GACTCTTCCTTTGC.
GAPDH: S, TCCAGTATGACTCTACCCACG; AS, CA
CGACATACTCAGCACCAG.
To determine the changes in protein abundance,
immunoblots were performed as described in the same
references (Martın-Pardillos et al. 2013, 2014) using a
Trans-Blot Turbo Transfer System, and detection was per-
formed using a VersaDoc MP 4000 System (both from
Bio-Rad, Hercules, CA), after lysing the VSMC in RIPA
buffer (50 mmol/L Tris pH 7.5, 150 mmol/L NaCl, 0.1%
SDS, 0.5% deoxycholate, 1% Triton X-100, and a protease
inhibitor cocktail, Sigma-Aldrich, St Louis, MO). Protein
was quantified using a BCA kit (Pierce BCA Protein
Assay; Thermo Scientific, Rockford, IL). In some cases,
information was confirmed by immunofluorescence
microscopy, using an Axiovert 200M fluorescent micro-
scope equipped with Apotome (Carl Zeiss, Jena, Ger-
many), also as reported (Martın-Pardillos et al. 2013). In
this case, the exposure time was automatically adjusted to
the maximal expression sample, and this time was fixed
for the remaining exposures of the same antibody. The
commercial antibodies used were the following: a mouse
monoclonal antibody for a-actin (cat. A5228 from Sigma-
Aldrich); mouse monoclonal antibodies anti-p21 for
immunoblot (cat. sc-6246 from Santacruz, Heidelberg,
Germany) and for immunofluorescence (cat. P1484, from
Sigma, St. Louis, MO); a goat polyclonal anti-SM22a (cat.
sc-18513; Santacruz); a mouse monoclonal anti-b-actin
antibody (cat. A1978; Sigma); and a rabbit anti-phospho-
p38 (cat. P1491; Sigma).
Senescence characterization
Senescence was quantified by the activity of senescence-
associated b-galactosidase (SA b-gal) at pH 6, as described
(Itahana et al. 2013; Martın-Pardillos et al. 2013), using
5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (Sigma),
after fixing the cells with paraformaldehyde.
Telomerase activity was determined by a fluorescence-
based telomeric repeat amplification protocol (TRAP)
using a TRAPEZE XL Telomerase Detection Kit (Milli-
pore International, Inc., Darmstadt, Germany). Fluores-
cence was quantified using a DTX 880 Multimode plate
reader (Beckman Coulter, Fullerton, CA).
Calcification experiments
For calcification in vitro, quiescent VSMC in MEM were
incubated with 2 mmol/L Pi for 10 days. Pi was diluted
from a stock of 100 mmol/L KH2PO4/K2HPO4, pH 7.4.
To visualize calcium deposits, cultures were stained with
0.5% alizarin red (pH 4.1–4.3) for 15 min. Calcium was
quantified colorimetrically using a Calcium Assay kit
(Abnoba, Taipei City, Taiwan), after overnight solubiliza-
tion of calcium with 0.6 N HCl at 4°C.
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Apoptosis
Apoptosis was determined by terminal deoxynucleotidyl
transferase-mediated dUTP Nick End Labeling assay,
using a CLICK-IT TUNEL Alexa Fluor Imaging Assay
(Molecular Probes, Eugene, OR), and visualized in an
Axiovert 200M fluorescent microscope.
Statistics
Prism 5.0 software (GraphPad Software Inc., La Jolla,
CA) was used for statistics, data representation, and linear
regressions. Significant differences were determined using
a one-way analysis of variance and Tukey’s multiple com-
parison post test. Asterisks indicate significant differences
when ANOVA P-values are <0.05 and the Tukey’s test
indicates significant differences in means.
Results
Proliferation characteristics
Vascular smooth muscle cells were obtained from the aor-
tas of 2-, 12-, and 24-month-old rats, which originated
from the three CL of the study, namely 2CL, 12CL, and
24CL. After 17 CPD of culture stabilization, VSMC
growth was characterized, with analyses performed at 17,
40, 70, and 90 CPD for all three cultures. The growth
characteristics are summarized in Figure 1, which shows
that after 100 CPD and over 230 days in culture, the cells
kept dividing, with no signs of division arrest for any of
the three cultures. The relationship between CPD and
days of culture were similar in all three cultures, with a
pooled slope of 0.42 CPD per day (Fig. 1A). Nevertheless,
2CL accumulated more cells than the 12CL and 24CL cul-
tures, with a slope of 2.18 9 106 cells per CPD, compared
to 1.45 9 106 and 1.28 9 106 cells/CPD for 12CL and
24CL, respectively (Fig. 1B). The differences between
these slopes were extremely significant (F = 368.13,
P < 0.0001). When we compared the divisions per day to
the CPD, the differences in the slopes were very signifi-
cant and followed the same trend 2CL > 12CL > 24CL
(P = 0.00126; Fig. 1C), meaning a progressive slowing
down of cell division according to the donor age. Finally
and surprisingly, when we compared cell density (cells
per cm2) to the CPD, in all three CL, the density
increased with the CPD at a rate of 1300 cells per CPD,
given that the slopes were statistically similar (Fig. 1D).
The 2CL slope was parallel, but it started at a higher
density.
Phase contrast microscopy (Fig. 1E) revealed that the
morphology of the cells changed to a longer, fibroblast-
like morphology with the proliferative age (from 17 to
90 CPD), but it was apparently similar in all three
donor ages. The cell number increased with the CPD,
as shown in Figure 1D, and the cells progressively
acquired a fibroblast-like morphology, especially after 70
CPD.
Expression of VSMC markers
We also wanted to know if the smooth muscle cell phe-
notype was maintained during the cultures. The contrac-
tile phenotype of VSMC was determined by analyzing the
expression of the differentiation markers a-actin and
SM22a in the three CL, as a function of both the prolifer-
ative and the chronological ages. Figure 2 shows the effect
of donor (chronological) age by comparing the expression
of both VSMC markers (plus b-actin as a control) in
2CL, 12CL, and 24CL within each CPD group, and it
shows the quantitative densitometry of the bands for 17
and 90 CPD. The abundance of both markers was slightly,
but significantly lower according to the donor age in all
three CL. The expression of a-actin in 12CL and 24CL
was 0.8 and 0.7 times less, respectively, when compared
to 2CL at 17 CPD. SM22a, however, was only lower in
24CL (0.7 times less compared to 2CL). The difference of
the expression in 12CL and 24CL with respect to 2CL
increased dramatically with the CPD, such that the
expression of a-actin in 12CL at 90 CPD was 0.2 times
less that of 2CL, and it was hardly visible in 24CL. A sim-
ilar pattern was observed for the abundance of SM22a
protein and RNA. These changes in protein expression
were confirmed by immunofluorescence microscopy
(Fig. 2B).
Changes in a-actin and SM22a expressions as a func-
tion of the proliferative age of the three CL are compiled
in Figure 3. The results confirm that the expression of
both VSMC markers diminished considerably as the CPD
increased, and it even disappeared at 90 CPD of 12CL
Figure 1. Proliferation of rat aortic smooth muscle cells from rats of 2-, 12-, and 24-month-old. (A) Cumulative population doublings (CPD) as
a function of days in culture, showing no differences between the three cell lines. (B) Total number of cells grown as a function of CPD. (C)
Relationships between the number of divisions per day and CPD, showing the corresponding regression lines. (D) Cell density as a function of
CPD. (E) Representative microphotographs of vascular smooth muscle cells from donor rats of 2-, 12- and 24-month-old at the indicated CPD.
Bar, 50 lm.
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Figure 2. Expression of smooth muscle markers a-actin and SM22a as a function of donor age within each cumulative population doublings
(CPD). (A) Immunoblot of both markers and quantitation with respect to b-actin expression. Only the expression quantifications at the 17th and
90th CPDs are shown. Right panels, SM22a RNA expression analyses by real-time PCR. (B) Immunofluorescence microphotographs of the two
markers. Bar, 50 lm.
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and 24CL. These findings were also confirmed by micro-
scopy (data not shown).
Senescence of VSMC
Although the cells did not arrest due to proliferation even
after 100 CPD, we checked for the presence of senescence
markers, such as b-galactosidase and telomerase activity.
For senescence-associated b-galactosidase activity, the cor-
responding staining was done using VSMC from 2CL,
12CL, and 24CL, measured at 17, 30, 70, and 90 CPD.
The representative images are shown in Figure 4A, thus
showing the mean number of cells per microscopy field at
1009. The cells from 2- and 12-month-old rats only
Figure 3. Expression of smooth muscle markers a-actin and SM22a as a function cumulative population doublings (CPD) within each donor
age. Top, immunoblot of both markers plus b-actin. Bottom, densitometric quantitation of the signals in immunoblots and SM22a RNA
quantitation.
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2015 | Vol. 3 | Iss. 11 | e12626
Page 7
A. Martın-Pardillos & V. Sorribas In Vivo and In Vitro Aging of Vascular Cells
showed a clear increase in staining at 90 CPD. The cells
from 24-month-old rats, however, also showed a minimal,
but evident increase at 70 CPD.
The effects of donor age and proliferation did not have
significant effects on telomerase activity. These results are
summarized in Figure 4B, which shows that in all three
CL the total telomere product was similar, with a trend
of decreasing activity as the CPD increased, but the
changes were not statistically different.
Apoptosis
The effect of CPD and donor age on the apoptosis rate of
VSMC was studied by conducting a TUNEL assay and an
analysis of caspase-3 activity (Fig. 5). Fluorescent TUNEL
revealed that apoptotic cells increased with both CPD and
rat age within each CPD, which was confirmed by count-
ing the apoptotic cells in four different centered fields of
each experimental condition (donor age and CPD). The
apoptosis increase was biochemically confirmed by mea-
suring caspase-3 activity (Fig. 5B), but in this case, the
increase was only observed in VSMC from 24-month-old
rats, compared to the VSMC from 2-month-old rats. The
increase in caspase-3 activity was also observed with
respect to CPD, especially at 70 and 90 CPD in 2CL and
24CL.
p21Cip1 (cyclin-dependent kinase inhibitor 1) expres-
sion and its accumulation with CPD were analyzed by
western blot because this expression is related to apopto-
sis and senescence (cell cycle arrest). p21 expression at
early CPD (17 and 30 CPD) increased with the age of the
animal, while at 70 and 90 CPD, p21 expression nearly
disappeared in the VSMC from 12- and 24-month-old
animals (Fig. 5C). When the expression of p21 was corre-
lated with CPD, p21 expression increased with CPD in
12CL and 24CL, even if the cells did not stop dividing
(Fig. 5D).
Oxidative stress
Aging-related oxidative stress was analyzed in the three
CL as a function of donor age and proliferative lifespan.
First, we analyzed the expression of phospho-p38, a MAP
kinase activated by several cell stresses, including the
Figure 4. Characterization of cell senescence in vascular smooth muscle cells (VSMC). (A) Microphotographs of VSMC stained for b-
galactosidase activity. Bar, 100 lm. To the right of the pictures, chart of the means of b-galactosidase-positive cells per microscopy field at 100
times magnification. (B) Telomerase activity as a function of donor age and cumulative population doublings (CPD).
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oxidation increase that occurs in aging (Ragnauth et al.
2010; Gutierrez-Uzquiza et al. 2012). Figure 6 shows that
the expression of stress-response protein phospho-p38 did
not significantly change with the CPD in any of the three
CL (A) or as a function of donor age (B). To confirm
that the absence of cell stress evidence also meant the
Figure 5. Analysis of apoptosis in cultured vascular smooth muscle cells (VSMC). (A) Microphotographs of VSMC stained with fluorescent
TUNEL as a function cumulative population doublings (CPD) from 2-, 12-, and 24-month-old rats and merged with phase contrast to show all
present cells. Bar, 100 lm. The frequency of TUNEL-positive nuclei after counting in microscope fields is shown to the right. (B) Caspase-3
activity as a function of donor age and CPD. (C) Expression of p21 as a function of donor age at 17 and 90 CPD. (D) Expression of p21 as a
function of donor CPD in 2-, 12-, and 24-month-old rats. Histograms, quantification of western blot signal densities with respect to b-actin.
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absence of oxidative damage accumulation, the protein
carbonyl content was also analyzed, thereby revealing no
changes in the oxidative status of the cells, either as a
function of donor age or proliferative age (Fig. 6C).
Osteogene expression
RNA was obtained from the cells of 2CL, 12CL, and
24CL maintained in regular MEM and at the same CPD
as above. The basal expressions of the Msx2, Runx2, and
Bmp2 osteogene RNAs were analyzed by real-time PCR.
The results are summarized in Figure 7. The effect of
donor age on osteogene expression is shown for 17 and
90 CPD. It was found that the Msx2 and Runx2 expres-
sions were similar in the three CL at 17 CPD, but these
expressions considerably increased with age at 90 CPD.
Bmp2 abundance, however, increased considerably in
24CL at all CPDs.
An analysis of relative expression as a function of CPD
revealed that all Msx2 and Runx2 expressions increased
with the CPD, while Bmp2 showed a dramatic increase at
an advanced CPD (Fig. 7B). The increase was similar in
all three CL.
Finally, the RNA expression of a major anticalcifying
protein, MGP, was also analyzed in the same samples,
revealing a decrease in expression as donor age and pro-
liferative age increased in all three CL. Figure 7C shows
the expression of MGP as a function of CPD for the three
donor ages.
Response to 2 mmol/L Pi treatment
Vascular smooth muscle cells from the three CL and four
CPDs were incubated in MEM with 2 mmol/L Pi for
10 days to study the response of the cells to a classical
calcification medium. Staining with alizarin red revealed
that calcium deposition increased with the CPD, but the
donor age variable had no effect on the deposited calcium
at any CPD (Fig. 8A). These data were confirmed with
alizarin red staining (Fig. 8B).
Discussion
Medial VC is extremely common in the elderly (Blumen-
thal et al. 1944). However, while the hemodynamic com-
plications are similar to those that affect renal patients,
Figure 6. Analysis of oxidative stress as a function of donor age and cumulative population doublings (CPD). (A) Expression of phosphorylated
p38 as a function of CPD in the three donor ages. (B) Expression of phospho-p38 as a function of donor age at 17 and 90 CPD. 30 and 70
CPD also did not show effects on p38 expression. (C) Analysis of protein oxidation as molar carbonyl content, as a function of donor age and
CPD.
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Figure 7. Effect of age and cumulative population doublings (CPD) on osteogene expression and transdifferentiation. (A) Expression of Msx2,
Runx2, and Bmp2 as a function of donor age at 17 and 90 CPD. (B) Expression as a function of CPD and different donor ages. (C) Expression
of MGP as a function of CPD at the three donor ages.
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the outcomes are usually less severe (Roosens et al. 2012),
as evidenced by the fact that MVC is usually accidentally
described in the elderly population when diagnosing other
disorders. During the last decade, many studies have
addressed several aspects of arterial smooth muscle cell
aging, and they show a correlation between VSMC senes-
cence and age-related arterial dysfunctions. This correla-
tion has been made based on the assumption that
proliferative aging (in vitro) is similar to cell aging
in vivo (Hayflick 1965; Campisi 2013). Studies have
revealed, for example, that human VSMC aged in vitro
showed an increase in the expression of senescence mark-
ers such as p16 and p21 and an increase in senescence-
associated b-galactosidase activity, as well as an increase
Figure 8. Effect of age and proliferation on the calcium deposition caused by 2 mmo/L Pi in minimum essential medium. (A) Effect of donor
age at all four cumulative population doublings (CPDs). (B) Effect of CPD at all three donor ages. (C) Alizarin staining of calcium deposits of the
indicated experimental conditions. Bar, 200 lm.
2015 | Vol. 3 | Iss. 11 | e12626
Page 12
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
In Vivo and In Vitro Aging of Vascular Cells A. Martın-Pardillos & V. Sorribas
in the abundance of several bone-related genes such as
alkaline phosphatase, Runx2, or collagen I, in addition to
a reduction in MGP expression (Nakano-Kurimoto et al.
2009). Bmp2 and Msx2 expressions were not modified by
replicative senescence, and osterix was somewhat less. A
concurrent study, which also analyzed the human senes-
cent VSMC gene expression profile using the microarray
approach, expanded the analysis to inflammation and tis-
sue remodeling genes (Burton et al. 2010). The study
found overexpression of Bmp2 in senescent cells and the
inhibition of MGP and osteoprotegerin, among other
genes. Nevertheless, gene expression changes do not occur
exclusively with senescence, and VSMC cultures dramati-
cally change the expressed genome according to the pro-
liferative activity and confluence (Absher et al. 1989;
Shanahan et al. 1993), thereby making it more difficult to
compare in vivo and in vitro VSMC phenotypes.
In this work, we have used primary cultures of rat
VSMC, because laboratory rats, like humans, show
increasing medial VC with age (Roosens et al. 2012). We
have studied the age-related changes of VSMC regarding
the two age concepts: proliferative aging (in vitro) and
chronological aging (in vivo). To do so, we established
three CL of VSMC obtained from groups of rats that
were 2-, 12-, and 24-months-old, which led to longitudi-
nal and transversal studies. First, we summarized the cul-
ture growth characteristics of the three CL (Fig. 1), with
the remarkable finding that no signs of proliferative aging
or senescence were observed, even after 100 CPD. Only a
reduction in the total number of cells was observed in
12CL and 24CL (Fig. 1B), as well as a progressive reduc-
tion in the cell divisions per day according to the CPD
(Fig. 1C), compared to 2CL. The limited effects on rat
VSMC proliferation are not common to all species, for
example, human VSMC show a reduced cell division rate
as donor age increases (Bierman 1978; Ruiz-Torres et al.
1999). The absence of cell senescence was corroborated by
staining for b-galactosidase activity (with the exception of
a slight increase at 90 CPD in VSMC from 24-month-old
rats) and a constant telomerase rate, which agrees with
previous findings that report telomerase induction during
rat VSMC proliferation (Fig. 4) (Minamino and Kourem-
banas 2001). In addition, the absence of apparent oxida-
tive stress (Fig. 6) also agrees with the absence of
senescence because oxidative stress is a known cause of
the senescence-associated secretory phenotype, DNA dam-
age and growth arrest, and telomere shortening (Campisi
2013). We used p38 activation as a marker of several
stresses, even though this MAK kinase has been tradition-
ally used as evidence of oxidative damage (Ragnauth et al.
2010; Gutierrez-Uzquiza et al. 2012). The absence of
phospho-p38 overexpression, therefore suggests that not
only was oxidative stress not present in the cells, but also
no other mechanisms of stress and stimuli that could
activate this MAP kinase (osmostress, ultraviolet light,
heat shock, cytokines, etc.) were significantly affecting the
cultures (de Nadal et al. 2011). Rather than senescence,
we observed a clearly increasing rate of VSMC apoptosis
as the CPD increased (Fig. 5). A TUNEL assay revealed
that, in addition to the effect of CPD in vitro, apoptosis
also increased with donor age. However, this effect is only
clearly observed at early CPD because at 70 and 90 CPD,
the VSMC from 2CL showed the highest apoptosis rate.
While the findings were less evident when caspase-3 activ-
ity was determined, this assay corroborated the trend of
an increasing apoptotic rate with the increase in both
proliferative and donor aging.
Given that the VSMC phenotype changes easily from
the synthetic (proliferating) to the contractile states
(Absher et al. 1989; Shanahan et al. 1993) in vitro, which
also seems to occur in vivo under certain circumstances,
we studied the expression of the VSMC phenotype during
the proliferative life in the three CL. The analyses of the
expression of aortic smooth muscle markers, such as a-
actin and SM22a, revealed a significant effect by donor
age, which was observed as early as 17 CPD and was
maximal at 90 CPD (Fig. 2). The effect of proliferative
aging was similar, but stronger than the effect of chrono-
logical aging (Fig. 3), and the effect increased as donor
age increased. Consequently, at the same time as this
apparent dedifferentiation, we also studied the conversion
of VSMC into an osteoblastic phenotype by measuring
the RNA expression of the Msx2, Runx2, and Bmp2
osteogenes (Fig. 7). Our results agreed with previous
reports (Nakano-Kurimoto et al. 2009; Burton et al.
2010) and showed evidence of osteoblastic transdifferenti-
ation with the progression of the proliferative life in all
three CL. The effect of donor age was, however, much
more limited. At early CPD, only Bmp2 clearly increased
in 24CL, but at late CPD, all three osteogenes increased
strongly in 12CL and 24CL, compared to 2CL. Con-
versely, the expression of the anticalcifying protein MGP
decreased with both donor age and proliferative age.
Finally, even if the incubation of VSMC at a high Pi
concentration is a very limited model of calcification
in vitro, with biological and chemical artifacts (Hortells,
Sosa, Millan, and Sorribas, manuscript under review), the
use of this protocol with the three CL and four CPDs has
provided findings that are consistent with the gene
expression results: calcium deposition is not affected by
donor age, but CPD has a moderate effect when VSMC
are incubated with 2 mmol/L Pi in MEM for 10 days
(Fig. 8).
We must stress that this study was limited to a com-
parison of the effects of donor age with the effects of pro-
liferation age, wherefore all the experiments were limited
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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to in vitro conditions. If a comparison is made directly
between the phenotypic changes observed in vitro and the
chronological aging of arteries in vivo, the magnitude of
the observed differences would be greater. The reason is
because the existence of arteries without contractile
VSMC (i.e., cells without smooth muscle markers such as
a-actin or Sm22a, as observed at 90 CPD, Fig. 3) has not
been observed in the elderly, and in fact, this transdiffer-
entiation would not be compatible with life. Based on
these relevant differences, the critical steps and conditions
of the method of VSMC aging in vitro should be analyzed
in detail. During a study of VSMC aging in vitro, there
are two critical steps that affect the VSMC phenotype and
survival selection: (1) the isolation of cells from the
artery, followed by the establishment of a culture, and (2)
the culture conditions and techniques during proliferative
aging. First, the isolation of VSMC by the collagenase diges-
tion of arteries and seeding is a very aggressive method of
cell selection. This selection occurs mostly according to the
state of health of the cells and also partly according to the
cell type. Moreover, the fact that fibroblasts could express
a-actin upon isolation and culture is an indication of possi-
ble cell contamination (e.g., Masur et al. 1996). During
proliferation, either after the first seeding or after every
trypsinization, the VSMC phenotype changes dramatically
from the contractile to the proliferating phenotype (Shana-
han et al. 1993; Shanahan and Weissberg 1998; Liu et al.
2015). After several passages and population doublings, this
plasticity is reduced in favor of cells with a fibroblast-like
morphology, which can be observed in Figure 1E and
which is corroborated by the dedifferentiation shown in
Figures 2 and 3 (Absher et al. 1989). The apparent changes
in gene expression during a long-term culture can be
caused by clonal selections during trypsinizations and
forced proliferation if the clones exhibit different growth
rates, but they can also be caused by the composition of the
culture media, the plastic support, the CO2 atmosphere,
culture manipulations, pH fluctuations, etc. All of these
stressing factors that do not occur in vivo can be affecting
the type of cells that survive in a culture during passages
and divisions, and therefore the relationship with the aging
process in vivo is questionable.
In conclusion, our findings reveal that, in vitro, rat
VSMC do not exhibit classical cell division arrest or
senescence (most likely because telomerase is induced) or
an increasingly oxidative steady state, which is a hallmark
of aging. We have also observed the previously reported
partial osteoblastic transition of VSMC that occurs during
the proliferative lifespan. However, given that senescence
in vitro does not take place and that no other characteris-
tics of aging were observed in the CL, special caution
should be observed when using the proliferative lifespan
of VSMC as a model of aging in vivo, as explained above.
For example, despite osteoblastic transition in vitro, this
transition has not been observed, or only minimally, as a
function of donor age. The same can be said about main-
tenance of the contractile phenotype, for which CPD has
a stronger effect than donor age.
We do not know the point up to which the prolifera-
tive lifespan of VSMC represents aging in vivo, but at a
minimum, the effects on osteoblastic transdifferentiation
are exaggerated in comparison to aging in vivo, and some
hallmarks of aging, such as oxidation product accumula-
tion, are not observed, despite the continuous elimination
of defective cells during proliferation. Therefore, any con-
clusion achieved using this in vitro model of aging should
be corroborated using arteries of old animals.
Conflict of Interest
None declared.
References
Absher, M., J. Woodcock-Mitchell, J. Mitchell, L. Baldor, R.
Low, and D. Warshaw. 1989. Characterization of vascular
smooth muscle cell phenotype in long-term culture. In
Vitro Cell. Dev. Biol. 25:183–192.
Bierman, E. L. 1978. The effect of donor age on the in vitro
life span of cultured human arterial smooth-muscle cells. In
Vitro 14:951–955.
Blumenthal, H. T., A. I. Lansing, and P. A. Wheeler. 1944.
Calcification of the media of the human aorta and its
relation to intimal arteriosclerosis, ageing and disease. Am.
J. Pathol. 20:665–687.
Burton, D. G., P. J. Giles, A. N. Sheerin, S. K. Smith, J. J.
Lawton, E. L. Ostler, et al. 2009. Microarray analysis of
senescent vascular smooth muscle cells: a link to
atherosclerosis and vascular calcification. Exp. Gerontol.
44:659–665.
Burton, D. G., H. Matsubara, and K. Ikeda. 2010.
Pathophysiology of vascular calcification: pivotal role of
cellular senescence in vascular smooth muscle cells. Exp.
Gerontol. 45:819–824.
Byon, C. H., A. Javed, Q. Dai, J. C. Kappes, T. L. Clemens, V.
M. Darley-Usmar, et al. 2008. Oxidative stress induces
vascular calcification through modulation of the osteogenic
transcription factor Runx2 by AKT signaling. J. Biol. Chem.
283:15319–15327.
Campisi, J. 2013. Aging, cellular senescence, and cancer. Annu.
Rev. Physiol. 75:685–705.
Chamley, J. H., G. R. Campbell, J. D. McConnell, and U.
Gr€oschel-Stewart. 1977. Comparison of vascular smooth
muscle cells from adult human, monkey and rabbit in primary
culture and in subculture. Cell Tissue Res. 177:503–522.
Chen, N. X., D. Duan, K. D. O’Neill, G. O. Wolisi, J. J.
Koczman, R. LaClair, et al. 2006. The mechanisms of
2015 | Vol. 3 | Iss. 11 | e12626
Page 14
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
In Vivo and In Vitro Aging of Vascular Cells A. Martın-Pardillos & V. Sorribas
uremic serum-induced expression of bone matrix proteins
in bovine vascular smooth muscle cells. Kidney Int.
70:1046–1053.
Cristofalo, V. J., C. Volker, and R. G. Allen. 2000. Use of the
fibroblast model in the study of cellular senescence. Pp. 23–
52 in Y. A. Barnett and C. R. Barnett, eds. Methods in
molecular medicine, vol. 38: aging methods and protocols.
Humana, Totowa, NJ.
Dai, X. Y., M. M. Zhao, Y. Cai, Q. C. Guan, Y. Zhao, Y.
Guan, et al. 2013. Phosphate-induced autophagy counteracts
vascular calcification by reducing matrix vesicle release.
Kidney Int. 83:1042–1051.
Dao, H. H., R. Essalihi, C. Bouvet, and P. Moreau. 2005.
Evolution and modulation of age-related medial
elastocalcinosis: impact on large artery stiffness and isolated
systolic hypertension. Cardiovasc. Res. 66:307–317.
Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C.
Roskelley, et al. 1995. A biomarker that identifies senescent
human cells in culture and in aging skin in vivo. Proc. Natl
Acad. Sci. USA 92:9363–9367.
Ewence, A. E., M. Bootman, H. L. Roderick, J. N. Skepper, G.
McCarthy, M. Epple, et al. 2008. Calcium phosphate crystals
induce cell death in human vascular smooth muscle cells: a
potential mechanism in atherosclerotic plaque
destabilization. Circ. Res. 103:e28–e34.
Gutierrez-Uzquiza, A., M. Arechederra, P. Bragado, J. A.
Aguirre-Ghiso, and A. Porras. 2012. p38a mediates cell
survival in response to oxidative stress via induction of
antioxidant genes: effect on the p70S6K pathway. J. Biol.
Chem. 287:2632–2642.
Hayflick, L. 1965. The limited in vitro lifetime of human
diploid cell strains. Exp. Cell Res. 37:614–636.
Itahana, K., Y. Itahana, and G. P. Dimri. 2013. Colorimetric
detection of senescence-associated b galactosidase. Methods
Mol. Biol. 965:143–156.
Kapustin, A. N., M. L. Chatrou, I. Drozdov, Y. Zheng, S. M.
Davidson, D. Soong, et al. 2015. Vascular smooth muscle
cell calcification is mediated by regulated exosome secretion.
Circ. Res. 116:1312–1323.
Kirkwood, T. B. 1977. Evolution of ageing. Nature 270:301–
304.
Lanzer, P., M. Boehm, V. Sorribas, M. Thiriet, J. Janzen, T.
Zeller, et al. 2014. Medial vascular calcification revisited:
review and perspectives. Eur. Heart J. 35:1515–1525.
Liu, Y., I. Drozdov, R. Shroff, L. E. Beltran, and C. M.
Shanahan. 2013. Prelamin A accelerates vascular calcification
via activation of the DNA damage response and senescence-
associated secretory phenotype in vascular smooth muscle
cells. Circ. Res. 112:e99–e109.
Liu, R., K. L. Leslie, and K. A. Martin. 2015. Epigenetic
regulation of smooth muscle cell plasticity. Biochim.
Biophys. Acta 1849:448–453.
Lopez-Otın, C., M. A. Blasco, L. Partridge, M. Serrano, and G.
Kroemer. 2013. The hallmarks of aging. Cell 153:1194–1217.
Martın-Pardillos, A., C. Sosa, and V. Sorribas. 2013. Arsenic
increases Pi-mediated vascular calcification and induces
premature senescence in vascular smooth muscle cells.
Toxicol. Sci. 131:641–653.
Martın-Pardillos, A., C. Sosa, A. Millan, and V. Sorribas. 2014.
Effect of water fluoridation on the development of medial
vascular calcification in uremic rats. Toxicology 318:40–50.
Masur, S. K., H. S. Dewal, T. T. Dinh, I. Erenburg, and S.
Petridou. 1996. Myofibroblasts differentiate from fibroblasts
when plated at low density. Proc. Natl Acad. Sci. USA
93:4219–4223.
Matthews, C., I. Gorenne, S. Scott, N. Figg, P. Kirkpatrick, A.
Ritchie, et al. 2006. Vascular smooth muscle cells undergo
telomere-based senescence in human atherosclerosis: effects
of telomerase and oxidative stress. Circ. Res. 99:156–164.
Minamino, T., and S. Kourembanas. 2001. Mechanisms of
telomerase induction during vascular smooth muscle cell
proliferation. Circ. Res. 89:237–243.
Minamino, T., H. Miyauchi, T. Yoshida, Y. Ishida, H. Yoshida,
and I. Komuro. 2002. Endothelial cell senescence in human
atherosclerosis: role of telomere in endothelial dysfunction.
Circulation 105:1541–1544.
de Nadal, E., G. Ammerer, and F. Posas. 2011. Controlling gene
expression in response to stress. Nat. Rev. Genet. 12:833–845.
Nakano-Kurimoto, R., K. Ikeda, M. Uraoka, Y. Nakagawa, K.
Yutaka, M. Koide, et al. 2009. Replicative senescence of
vascular smooth muscle cells enhances the calcification
through initiating the osteoblastic transition. Am. J. Physiol.
Heart Circ. Physiol. 297:H1673–H1684.
Neves, J., M. Demaria, J. Campisi, and H. Jasper. 2015. Of
flies, mice, and men: evolutionarily conserved tissue damage
responses and aging. Dev. Cell 32:9–18.
Ragnauth, C. D., D. T. Warren, Y. Liu, R. McNair, T. Tajsic,
N. Figg, et al. 2010. Prelamin A acts to accelerate smooth
muscle cell senescence and is a novel biomarker of human
vascular aging. Circulation 121:2200–2210.
Roosens, B., G. Bala, S. Droogmans, J. Hostens, J. Somja, E.
Delvenne, et al. 2012. Occurrence of cardiovascular
calcifications in normal, aging rats. Exp. Gerontol. 47:614–619.
Ruiz-Torres, A., A. Gimeno, J. Melon, L. Mendez, F. J. Mu~noz,
and M. Macıa. 1999. Age-related loss of proliferative activity
of human vascular smooth muscle cells in culture. Mech.
Ageing Dev. 110:49–55.
Shanahan, C. M., and P. L. Weissberg. 1998. Smooth muscle
cell heterogeneity: patterns of gene expression in vascular
smooth muscle cells in vitro and in vivo. Arterioscler.
Thromb. Vasc. Biol. 18:333–338.
Shanahan, C. M., P. L. Weissberg, and J. C. Metcalfe. 1993.
Isolation of gene markers of differentiated and proliferating
vascular smooth muscle cells. Circ. Res. 73:193–204.
Yang, D., D. J. McCrann, H. Nguyen, C. St Hilaire, R. A.
DePinho, M. R. Jones, et al. 2007. Increased polyploidy in
aortic vascular smooth muscle cells during aging is marked
by cellular senescence. Aging Cell 6:257–260.
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2015 | Vol. 3 | Iss. 11 | e12626
Page 15
A. Martın-Pardillos & V. Sorribas In Vivo and In Vitro Aging of Vascular Cells
